Blackstone Multi-Asset Investing

Funding rounds backed by Blackstone Multi-Asset Investing.

Export CSV
Funding disclosed in full
$330M
Median round
$330M
Rounds in calculation
1
1 round
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Ollin Biosciences

Develops bispecific antibody therapies for retinal vascular diseases including diabetic macular edema and wet AMD

$330MSeries BBiotechUnited States
10 participantsa16z Bio+HealthARCH Venture PartnersBlackstone Multi-Asset InvestingCanada Pension Plan Investment BoardCommodore CapitalMonograph CapitalMubadala CapitalRA Capital ManagementTCGXT. Rowe Price Investment Management